News Releases
DEADLINE TODAY: The Schall Law Firm Encourages Investors in Bausch Health Companies Inc. with Losses of $100,000 to Contact the Firm
Los Angeles, California–(Newsfile Corp. – September 25, 2023) – The Schall Law Firm, a national shareholder rights litigation firm, reminds investors…
Los Angeles, California–(Newsfile Corp. – September 25, 2023) – The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Bausch Health Companies Inc. (“Bausch” or “the Company”) (NYSE: BHC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Investors who purchased the Company’s securities between August 6, 2020 and May 3, 2023, inclusive (the ”Class Period”), are encouraged to contact the firm before September 25, 2023.
If you are a shareholder who suffered a loss, click here to participate.
We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at bschall@schallfirm.com.
The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.
According to the Complaint, the Company made false and misleading statements to the market. The Bausch + Lomb Corporation (“B+L”) spinoff would fail to result in two strong separate companies. Bausch was left overly leveraged without the cashflow generated by B+L. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Bausch, investors suffered damages.
Join the case to recover your losses.
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
CONTACT:
The Schall Law Firm
Brian Schall, Esq.
www.schallfirm.com
Office: 310-301-3335
info@schallfirm.com
SOURCE:
The Schall Law Firm
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/181744
nyse
tsx-blco
bausch-lomb-corporation
bausch lomb corporation
tsx-bhc
bausch-health-companies-inc
bausch health companies inc
press-release
nDatalyze Corp. (“NDAT” or the “Corporation”) (CSE:NDAT) (OTC:NDATF) Announces an Expansion of its YMI Validation Project
Calgary, Alberta – TheNewswire – October 17, 2023 – nDatalyze Corp. (“NDAT” or the “Corporation”) (CSE:NDAT) (OTC:NDATF) announces an expansion…
Telo Genomics Announces Clinical Launch of Non-Invasive Cancer Diagnostic, TeloViewSMM – An Important Commercial Milestone Achieved
TeloView Analyses Telomeres to Accurately Predict and Characterize Multiple MyelomaToronto, Ontario–(Newsfile Corp. – October 17, 2023) – Telo Genomics…
NervGen Pharma Appoints John Ruffolo to Board of Directors
Extensive experience in private equity, venture capital and advising high growth, innovative companiesBrings personal experience and knowledge of spinal…
